We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+42.24%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$431M
AUM Growth
+$40.6M
Cap. Flow
-$22.4M
Cap. Flow %
-5.2%
Top 10 Hldgs %
39.17%
Holding
104
New
21
Increased
36
Reduced
26
Closed
21

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$12.5M
2
AMGN icon
Amgen
AMGN
+$10.8M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.35M
4
DHR icon
Danaher
DHR
+$3.96M
5
FOCL
EDAP TMS S.A.
FOCL
+$3.61M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$13.2M
2
SDGR icon
Schrodinger
SDGR
+$10.4M
3
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$9.41M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$9.05M
5
GNMK
GenMark Diagnostics, Inc
GNMK
+$9.02M

Sector Composition

Rank Sector Weight
1 Healthcare 92.25%
2 Technology 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDXS icon
51
Codexis
CDXS
$172M
$2.29M 0.53%
+100,000
New +$2.34M
BCYC
52
Bicycle Therapeutics
BCYC
$284M
$2.25M 0.52%
+75,454
New +$1.95M
CRIS icon
53
Curis
CRIS
$3.49M
$2.22M 0.52%
490
+2
+0.4% +$8.36K
MTEM
54
DELISTED
Molecular Templates, Inc.
MTEM
$2.09M 0.49%
11,055
+381
+4% +$66.8K
GYRE icon
55
Gyre Therapeutics
GYRE
$706M
$1.97M 0.46%
52,216
+26,995
+107% +$1.23M
SURF
56
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1.97M 0.46%
252,244
+76,452
+43% +$764K
HAE icon
57
Haemonetics
HAE
$4.16B
$1.94M 0.45%
+17,500
New +$2.17M
ONEM
58
DELISTED
1Life Healthcare
ONEM
$1.77M 0.41%
45,217
-29,783
-40% -$1.4M
PROF
59
Profound Medical
PROF
$252M
$1.7M 0.39%
84,399
+15,350
+22% +$368K
SCTL
60
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$1.68M 0.39%
+601,967
New +$2.16M
TRIL
61
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.61M 0.37%
150,304
-14,281
-9% -$177K
PHLT
62
DELISTED
Performant Healthcare Inc
PHLT
$1.61M 0.37%
+750,000
New +$1.02M
ATEC icon
63
Alphatec Holdings
ATEC
$1.49B
$1.58M 0.37%
100,000
-402,655
-80% -$6.34M
MNKD icon
64
MannKind Corp
MNKD
$1.24B
$1.57M 0.36%
+400,000
New +$1.64M
NOTV
65
DELISTED
Inotiv
NOTV
$1.5M 0.35%
+75,000
New +$1.17M
KNSA icon
66
Kiniksa Pharmaceuticals
KNSA
$6.1B
$1.49M 0.35%
80,603
+5,603
+7% +$115K
FULC icon
67
Fulcrum Therapeutics
FULC
$284M
$1.48M 0.34%
+125,738
New +$1.55M
TPTX
68
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$1.32M 0.31%
13,962
-45,415
-76% -$5.4M
WHWK
69
Whitehawk Therapeutics
WHWK
$269M
$1.29M 0.3%
66,746
+49,121
+279% +$1.13M
TLMD
70
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$1.21M 0.28%
+192,127
New +$1.44M
BLRX
71
BioLineRX
BLRX
$11.7M
$1.2M 0.28%
10,753
+54
+0.5% +$6.49K
PHAT icon
72
Phathom Pharmaceuticals
PHAT
$742M
$1.14M 0.26%
+30,207
New +$1.26M
ASLN
73
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$1.09M 0.25%
+8,125
New +$1.03M
FBRX icon
74
Forte Biosciences
FBRX
$1.57B
$1.07M 0.25%
1,250
+6
+0.5% +$4.91K
SILK
75
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1.01M 0.24%
20,000
-47,854
-71% -$2.66M
1 2
3
4 5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Parkman Healthcare Partners held 104 positions worth $431M, up 10% from $390M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parkman Healthcare Partners withdrew a net $22.4M in Q1 2021, closing 21 positions and reducing 26 holdings. Its most notable exit was GW Pharmaceuticals Plc American Depositary Shares, an estimated $9.41M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 92% a quarter earlier, followed by Technology.

Against the trend, Parkman Healthcare Partners opened a new position in United Therapeutics worth $12.5M.

  • Parkman Healthcare Partners's largest Q1 2021 buy was United Therapeutics: 74,874 shares worth $12.5M.
  • Parkman Healthcare Partners added most to Alnylam Pharmaceuticals in Q1 2021, an estimated $4.35M increase.
  • Parkman Healthcare Partners's biggest Q1 2021 reduction was Vericel Corp, cutting an estimated $13.2M.
  • Parkman Healthcare Partners fully exited GW Pharmaceuticals Plc American Depositary Shares in Q1 2021, selling an estimated $9.41M.
  • Parkman Healthcare Partners's ten largest holdings make up 39% of its $431M portfolio in Q1 2021.
  • Parkman Healthcare Partners opened 21 new positions and closed 21 in Q1 2021.
  • Parkman Healthcare Partners's portfolio value rose 10% quarter-over-quarter to $431M.

Based on Parkman Healthcare Partners's 13F filing for Q1 2021, filed 14 May 2021.